167 related articles for article (PubMed ID: 18684320)
1. AIDS-related primary central nervous system lymphoma: a Norwegian national survey 1989-2003.
Haldorsen IS; Kråkenes J; Goplen AK; Dunlop O; Mella O; Espeland A
BMC Cancer; 2008 Aug; 8():225. PubMed ID: 18684320
[TBL] [Abstract][Full Text] [Related]
2. Increasing incidence and continued dismal outcome of primary central nervous system lymphoma in Norway 1989-2003 : time trends in a 15-year national survey.
Haldorsen IS; Krossnes BK; Aarseth JH; Scheie D; Johannesen TB; Mella O; Espeland A
Cancer; 2007 Oct; 110(8):1803-14. PubMed ID: 17721992
[TBL] [Abstract][Full Text] [Related]
3. CT and MR imaging features of primary central nervous system lymphoma in Norway, 1989-2003.
Haldorsen IS; Kråkenes J; Krossnes BK; Mella O; Espeland A
AJNR Am J Neuroradiol; 2009 Apr; 30(4):744-51. PubMed ID: 19164442
[TBL] [Abstract][Full Text] [Related]
4. Primary central nervous system lymphomas: incidence and survival in the Southern and Eastern Netherlands.
van der Sanden GA; Schouten LJ; van Dijck JA; van Andel JP; van der Maazen RW; Coebergh JW;
Cancer; 2002 Mar; 94(5):1548-56. PubMed ID: 11920513
[TBL] [Abstract][Full Text] [Related]
5. Incidence, clinical features, treatment and outcome of primary central nervous system lymphoma in Norway.
Salvesen Haldorsen I; Aarseth JH; Hollender A; Larsen JL; Espeland A; Mella O
Acta Oncol; 2004; 43(6):520-9. PubMed ID: 15370608
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic delay in primary central nervous system lymphoma.
Haldorsen IS; Espeland A; Larsen JL; Mella O
Acta Oncol; 2005; 44(7):728-34. PubMed ID: 16227164
[TBL] [Abstract][Full Text] [Related]
7. Incidence, clinicopathological features and outcome of primary central nervous system lymphomas. Population-based data from a Danish lymphoma registry. Danish Lymphoma Study Group, LYFO.
Krogh-Jensen M; d'Amore F; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
Ann Oncol; 1994 Apr; 5(4):349-54. PubMed ID: 8075032
[TBL] [Abstract][Full Text] [Related]
8. Trends in survival from primary central nervous system lymphoma, 1975-1999: a population-based analysis.
Panageas KS; Elkin EB; DeAngelis LM; Ben-Porat L; Abrey LE
Cancer; 2005 Dec; 104(11):2466-72. PubMed ID: 16240449
[TBL] [Abstract][Full Text] [Related]
9. Treatment patterns and prognosis in patients with human immunodeficiency virus and primary central system lymphoma.
Kreisl TN; Panageas KS; Elkin EB; Deangelis LM; Abrey LE
Leuk Lymphoma; 2008 Sep; 49(9):1710-6. PubMed ID: 18661394
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological features, survival and prognostic factors of primary central nervous system lymphomas: trends in incidence of primary central nervous system lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the Danish Lymphoma Registry, LYFO, and the Danish Cancer Registry.
Krogh-Jensen M; D'Amore F; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
Leuk Lymphoma; 1995 Oct; 19(3-4):223-33. PubMed ID: 8535213
[TBL] [Abstract][Full Text] [Related]
11. The management of primary central nervous system lymphoma related to AIDS in the HAART era.
González-Aguilar A; Soto-Hernández JL
Curr Opin Oncol; 2011 Nov; 23(6):648-53. PubMed ID: 21946245
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of primary CNS lymphoma.
Schabet M
J Neurooncol; 1999 Jul; 43(3):199-201. PubMed ID: 10563423
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with survival among patients with AIDS-related primary central nervous system lymphoma.
Uldrick TS; Pipkin S; Scheer S; Hessol NA
AIDS; 2014 Jan; 28(3):397-405. PubMed ID: 24076659
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy of primary central nervous system lymphoma in patients with and without human immunodeficiency virus. Ten years of treatment experience at the University of California San Francisco.
Ling SM; Roach M; Larson DA; Wara WM
Cancer; 1994 May; 73(10):2570-82. PubMed ID: 8174055
[TBL] [Abstract][Full Text] [Related]
15. Long-term survival in AIDS-related primary central nervous system lymphoma.
Gupta NK; Nolan A; Omuro A; Reid EG; Wang CC; Mannis G; Jaglal M; Chavez JC; Rubinstein PG; Griffin A; Abrams DI; Hwang J; Kaplan LD; Luce JA; Volberding P; Treseler PA; Rubenstein JL
Neuro Oncol; 2017 Jan; 19(1):99-108. PubMed ID: 27576871
[TBL] [Abstract][Full Text] [Related]
16. Natural history and prognostic factors for survival in patients with acquired immune deficiency syndrome (AIDS)-related primary central nervous system lymphoma (PCNSL).
Raez LE; Patel P; Feun L; Restrepo A; Raub WA; Cassileth PA
Crit Rev Oncog; 1998; 9(3-4):199-208. PubMed ID: 10201628
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus in acquired immune deficiency syndrome (AIDS) and non-AIDS primary central nervous system lymphoma.
DeAngelis LM; Wong E; Rosenblum M; Furneaux H
Cancer; 1992 Sep; 70(6):1607-11. PubMed ID: 1325277
[TBL] [Abstract][Full Text] [Related]
18. Human immunodeficiency virus-related primary central nervous system lymphoma: factors influencing survival in 111 patients.
Newell ME; Hoy JF; Cooper SG; DeGraaff B; Grulich AE; Bryant M; Millar JL; Brew BJ; Quinn DI
Cancer; 2004 Jun; 100(12):2627-36. PubMed ID: 15197806
[TBL] [Abstract][Full Text] [Related]
19. Trends in primary central nervous system lymphoma incidence and survival in the U.S.
Shiels MS; Pfeiffer RM; Besson C; Clarke CA; Morton LM; Nogueira L; Pawlish K; Yanik EL; Suneja G; Engels EA
Br J Haematol; 2016 Aug; 174(3):417-24. PubMed ID: 27018254
[TBL] [Abstract][Full Text] [Related]
20. A comparative study of multimodal magnetic resonance in the differential diagnosis of acquired immune deficiency syndrome related primary central nervous system lymphoma and infection.
Li J; Xue M; Yan S; Guan C; Xie R; Chen B
BMC Infect Dis; 2021 Feb; 21(1):165. PubMed ID: 33568094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
